We have transformed two peptide epitopes into D-peptide analogs: VPGSQHIDS derived from cholera toxin recognized by the antibody TE33, and GATPQDLNTML from the HIV-1 capsid protein p24 recognized by the antibody CB4-1. The transformation process was performed by stepwise substitution of each single epitope position by all 19 D-amino acids and glycine followed by antibody binding studies and selection of one D-analog for further transformation. Thus, each transformation step introduced one novel D-position into the peptide. For both epitopes complete D-analogs were obtained. The cholera toxin-derived variant dwGsqhydp binds to the antibody TE33 with higher affinity than its original epitope, whereas in the case of the p24-derived analog saGdwwGkssl lower affinity was detected. Both D-peptides are completely stable in serum for several days. Antibody interaction models for both D-molecules were generated by computer-assisted modelling based on the crystal structures of the starting complexes. Compared with the L-peptides, the binding conformation of dwGsqhydp is very similar, whereas saGdwwGkssl displays a completely different interaction mode.
Introduction
Peptide ligands often serve as lead structures for the purpose of drug discovery. They can be obtained from biologically or chemically generated libraries (for review see Pavia et al., 1993; Gallop et al., 1994; Eichler and Houghten, 1995) . However, the susceptibility to enzymatic degradation by naturally occurring proteases is a major drawback of L-peptide ligands as potential drug candidates. For that reason, elegant approaches to obtain biologically active D-peptides have been developed such as synthetic combinatorial D-libraries (Dooley et al., 1994) , rationally designed D-analogs (Jameson et al., 1994) or mirror image phage display (Schumacher et al., 1996) . Another field of application is immunology, where D-peptide enantiomers as well as retro-inverso isomers were applied in vaccine development, immunodiagnostics and the generation of immunomodulators (Benkirane et al., 1993 (Benkirane et al., , 1996 Guichard et al., 1994; Chorev and Goodman, 1995) . In nature D-or D-/L-mixed peptides occur in prokaryotes and eukaryotes and are produced by multi-enzyme complexes (for review see Kleinkauf and von Döhren, 1997) or posttranslational isomerization of L-amino acids (Heck et al., 1996 and literature cited therein). Furthermore, highly efficient D-peptide antibiotics and receptor agonists and antagonists have been described (Hayry et al., 1996; Boman, 1996; McDonnell et al., 1996; Kleinkauf and von Döhren, 1997) .
Antibody-peptide interactions are widely investigated models for protein-protein interactions (for reviews see Van Regenmortel, 1994; Webster et al., 1994; Wilson and Stanfield, 1994; Padlan, 1996) . Furthermore, as described above, this interaction is relevant with respect to several aspects of immunology. Although several X-ray structures of antibodypeptide complexes have been reported (for review see Webster et al., 1994; Wilson and Stanfield, 1994; Padlan, 1996) , little is known how D-peptides or L-/D-mixed peptides recognize monoclonal antibodies . In these antibodypeptide complexes the peptides bind to a binding cleft formed by the six hypervariable loops called complementarity determining regions (CDRs).
In the past, high affinity binding monoclonal antibodies were often thought to be monospecific, meaning that one antibody molecule is only capable of recognizing one specific epitope. However, cross reactivities of antibodies with homologous molecules were observed. With the generation of synthetically and biologically generated peptide libraries it became obvious that even high affinity binding antibodies are able to recognize unrelated molecules (De Ciechi et al., 1995; Pinilla et al., 1995; Appel et al., 1996; Demangel, 1996; Kramer et al., 1997) . The observation of polyspecificity was the consequence of being able to test enormous pools of different peptides. Keitel et al. (1997) describe one example how such polyspecificity is structurally accomplished. In this case two unrelated L-peptides and one D-peptide bind to the same site of the monoclonal antibody CB4-1 in different conformations by using different antibody side chains of the binding cleft formed by the heavy and light chain.
The observation that the monoclonal antibody CB4-1 is able to recognize different L-and D-peptides led us to question whether it would be possible to transform L-peptide epitopes into binding D-analogs by stepwise transformation introducing one novel D-substitution at each cycle by screening substitutional D-analog libraries (Stigler et al., 1995) . This approach would reduce the number of analogs that have to be synthesized to a few hundred rather than screening large combinatorial libraries (Schneider-Mergener et al., 1996; Kramer et al., 1997) . Here we describe the stepwise transformation of two peptides, a cholera toxin and a p24 (HIV-1) epitope into D-analogs using spot synthesis (Frank, 1992) . For the two starting peptides, VPGSQHIDS recognized by the antibody TE33 and GATPQDLNTML recognized by the antibody CB4-1, the X-ray structures of the peptides in complex with the respective antibody have been solved (Shoham, 1993; Keitel et al., 1997) . Binding affinities of all transformation analogs and stability towards enzymatic degradation in serum were investigated. For both D-analogs structural aspects of interaction with their respective antibodies obtained with molecular modelling techniques will be described.
Materials and methods

Peptide synthesis
Cellulose-bound peptides were prepared by automated spot synthesis (Abimed, Langenfeld, Germany; Software DIGEN, Jerini BioTools GmbH, Berlin, Germany) using Whatman 50 (Whatman, Maidstone, UK) cellulose membranes (Frank, 1992) , as described previously in detail Kramer and Schneider-Mergener, 1998) . The peptides for the solution phase experiments (ELISA and serum stability) were prepared according to standard Fmoc machine protocols using a multiple peptide synthesizer (Abimed, Langenfeld, Germany) and analyzed by reversed-phase HPLC and MALDI-TOF mass spectrometry. Peptides potentially recognized by the antibody CB4-1 were N-terminally acetylated using acetanhydride and diisopropylethylamine. Antibody binding studies on cellulose membranes Membranes were blocked overnight with blocking buffer, i.e. blocking reagent (CRB, Northwich, UK) in T-TBS (Tris buffered saline/0.05% Tween 20) containing 1% sucrose. After washing with T-TBS, 0.1-1 µg/ml of the respective antibody (CB4-1 or TE33) in blocking buffer was added and incubated for 3 h at room temperature. After washing three times with T-TBS, a peroxidase-labelled anti-mouse antibody (Sigma, München, Germany; 1 µg/ml in blocking buffer) was applied for 2 h at room temperature. For detection, a chemiluminescence system was applied using standard X-ray films or the LumiImager™ (Boehringer Mannheim GmbH, Mannheim, Germany).
Competitive ELISA studies For determination of antibody-peptide binding affinities, microtiter plates (Nunc, Roskilde, Denmark) were coated with 0.1 µg/ml recombinant p24 (for CB4-1-peptide interaction) and 1 µg/ml cholera-derived peptide VPGSQHIDSQ (for TE33-peptide interaction) in 0.1 M sodium carbonate buffer (pH 9.6) and incubated for 20 h at 4°C. After washing three times with PBS/0.1% Tween 20, 0.1 µg/ml horseradish peroxidase-labelled CB4-1 and TE33, respectively, was added with peptides in various concentrations (depending on the respective inhibition constants) in PBS/0.1% Tween 20 containing 6% Gelifundol ® S (Biotest, Dreieich, Germany) in a total volume of 50 µl for 20 h at 4°C. After washing three times with PBS/0.1% Tween 20, the bound enzyme activity was determined by adding 5.5 mM o-phenylenediamine hydrochloride (Fluka, Buchs, Switzerland) and 8.5 mM H 2 O 2 in 0.1 M citrate buffer, pH 5.0. The reaction was terminated after 10 min by adding 1 M sulfuric acid containing 0.05 M sodium sulfite. The absorbance was measured at 492 and 620 nm, as reference, using an ELISA reader (Anthos, Köln, Germany). Inhibition constants were calculated according to Friguet et al. (1985) . Stability of peptides in fetal calf serum Peptides (2 mg/ml) were incubated in fetal calf serum (Biochrom, Berlin, Germany) at 37°C for different durations (0, 1, 5, 25 and 125 h) and analyzed by reversed-phase HPLC (C18 column, Vydac, Hesperia, CA). The percentage of peptides which had not been degraded by serum proteases was quantified by integrating the HPLC peak areas.
Computer modelling experiments
All calculations were performed on a Silicon Graphics workstation using the programs QUANTA (Copyright MSI Inc.),
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CHARMm (Brooks et al., 1983) and ICM . The coordinates of the TE33-peptide complex (Shoham, 1993) were used as a starting point for modelling the complex of TE33 with the D-peptide vpGsqhyds. Due to better refinement, the coordinates of CB4-1 in complex with the epitope homologous peptide GATPEDLNQKL rather than the epitope GATPQDLNTML served as a starting point for modelling the complex with the D-peptide dwwGkssl.
The D-peptide vpGsqhyds was modelled using CHARMm, with the binding conformation of the L-peptide epitope as a template. The D-peptide was first set up as an extended strand, then the backbone conformation of this peptide was adopted to that of the epitope via CHARMm minimization under distance restraints (template forcing). The whole complex was energy-minimized to a local minimum with a cut-off radius for non-bonded interactions of 15 Å and distance-dependent dielectrics using the conjugate-gradient algorithm (Fletcher and Reeves, 1977) including water molecules present in the crystal structure of the TE33-peptide complex, as some of the waters mediate interactions between the peptide and the antibody.
The complex of antibody CB4-1 with the D-peptide dwwGkssl was modelled using ICM with an extended conformation and the same orientation of peptide as a starting point. The peptide was placed near the putative binding site and 1 500 000 Monte-Carlo steps with Brownian-like random moves of the ligand were performed. Side chain conformations of the peptide and those of the antibody residues up to 6 Å away from the peptide were sampled using the biased-probability algorithm . After each MonteCarlo random step, a local energy minimization using the conjugate-gradient algorithm was performed. The backbone of the antibody was kept fixed. Electrostatics was accounted for using the REBEL approximation, which includes an efficient algorithm for solving the Poisson-Boltzman equation (Zauhar and Morgan, 1985) . The lowest-energy conformations are displayed in Figure 3 .
Results
Stepwise L-epitope to D-analog transformation From the starting peptides VPGSQHIDS (P1) (cholera toxinderived) and GATPQDLNTML (P2) (p24-derived) complete substitutional analyses were performed exchanging each single position of the epitopes by all 19 D-amino acids and also glycine (Stigler et al., 1995; Kramer et al., 1997) . Subsequently, binding of the substitution D-analogs to the anti-cholera toxin antibody TE33 or the anti-p24 antibody CB4-1 was tested (Figures 1 and 2 ). In the peptide VPGSQHIDS the six N-terminal residues are highly sensitive to D-substitution whereas in the peptide GATPQDLNTML most positions can be substituted by one or more D-amino acids.
In the case of P1 the analog VPGSQHIDp (P1 1 ) (small letters represent D-amino acids) was chosen as starting peptide for the second set of substitutions. Other selections would have been possible. Due to limitations in the number of peptides that can be synthesized, we followed only one possible transformation route. In the second step we introduced D-aspartic acid at position 7. In the substitutional analysis based on the peptide VPGSQHdDp (P1 2 ) a weak binding spot was observed for the exchange of serine 4 by D-isoleucine. This peptide was chosen although substitutions at aspartic Starting with P1 (VPGSQHIDS) each residue of the peptide was substituted by 19 D-amino acids and glycine (rows) and analyzed for TE33 binding. The spots in the left column are identical and correspond to the starting peptide. In the next step peptide P1 1 (VPGSQHIDp) containing one D-proline (p) was selected (arrow) for the next rounds of substitutions ending up with the D-peptide dwGsqhydp (P1 10 ). To display key residues for interaction of the original epitope VEVPGSQHIDSQ (Shoham, 1993) , a complete substitutional analysis (upper left) using L-amino acids is shown for comparison. Since the two N-terminal residues VE and the C-terminal Q can be deleted without loss of binding and these three residues can be substituted by all other amino acids (data not shown), all experiments were performed with the minimal binding epitope VPGSQHIDS. The exposure time of each substitutional analysis differs. The relative spot intensities within each substitutional analysis qualitatively correlate with the binding affinities . acid 8 led to stronger binding peptides. The rationale to select the peptide VPGiQHdDp (P1 3 ) was to introduce a binding substitution into the highly sensitive N-terminus. We speculated that an additional substitution might then again increase the affinity of the peptide P1 3 . This was not the case, but several substitutions with similar spot intensities occurred. Substitutions in the next analog VPGiQHddp (P1 4 ) now led to stronger binding peptides in the N-terminal region. The left column of the substitution set does not show any binding due to shorter exposition time compared with the preceding set of substitutions. A further increase in affinity was observed for several analogs now derived from VwGiQHddp (P1 5 ). In this case the strongest spot corresponding to VwGiQHydp (P1 6 ) was chosen because this substitution led to considerably stronger binding. This step turned out to be useful because P1 6 now tolerates a broad spectrum of D-substitutions. The substitutional analysis based on P1 6 now clearly indicates that a complete transformation into a D-analog is possible. This is shown in Figure 1 by preparing four additional sets of substitution analogs leading to the D-peptide dwGsqhydp. In this peptide (P1 10 ) glycine 3 can be substituted by all other 19 D-enantiomers without loss of binding.
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The same procedure was performed for the peptide GATPQDLNTML (P2) as shown in Figure 2 leading to the final peptide saGdwwGkssl (P2 11 ) in 11 steps. In contrast to the transformation of P1, at each step binding of the corresponding soluble peptides (K D Ͻ 10 -4 M) was detected. However, the final affinity of P2 11 was lower than the starting peptide (Table I) , whereas the transformation of P1 led to a D-analog with higher affinity than the original epitope. The binding affinities for the P1 analogs vary from 10 -6 M to Ͼ10 -4 M as tested in competitive ELISA studies with soluble peptides. The affinities pass a minimum between the third and sixth step and slightly increase at the seventh step. After a decrease in the eighth step, step nine already leads to the final affinity of~10 -6 M. For P2-derived analogs the affinity increases roughly 10-fold in the first step, but then decreases to~10 -6 M in the third step to again increase 10-fold in the fourth and fifth step. From then a decrease is observed which stabilizes at the eighth step to be constant at~10 -5 M.
The stability of both final D-peptides and selected intermediates towards proteolysis was tested in fetal calf serum. The final D-analogs were completely stable in serum for several days (Table I ). In contrast, the half-life times of P1 and P2 Fig. 2 . Transformation of the p24 epitope GATPQDLNTML into the D-peptide saGdwwGkssl being recognized by the monoclonal antibody CB4-1. Transformation was carried out as described in Figure 1 . Key residues for interaction of the epitope displayed by a substitutional analysis using L-amino acids is displayed in Schneider-Mergener et al. (1996) . were roughly 2 and 20 h, respectively. It also became obvious that already the introduction of a few D-residues into the epitope significantly enhances stability towards proteolytic digestion. For the two peptides investigated here, the substitution of only a few residues rendered the peptides inert to protease digestion (Table I ).
Molecular models of the D-peptide-antibody interaction
It has not been possible so far to co-crystallize the antibodies and their D-peptide epitopes. Therefore, three-dimensional models for the complex between TE33 and the D-peptide vpGsqhyds and CB4-1 and dwwGkssl (for choice of these sequences see below), respectively, are proposed using computer-assisted modelling, to gain insight into the binding modes. The modelling was based on the crystal structures of complexes of the antibodies with their peptide epitopes and further supported by the binding data obtained from the epitope substitution libraries. The screening of the epitope analogs revealed key residues for interaction of the peptides with the antibodies. These data were compared with the suggested structural models. For the docking experiments the D-peptide vpGsqhyds was deduced from the final substitutional analysis of peptide dwGsqhydp in which d1, w2 and p9 can be exchanged by all other residues. The substitutional analysis of the docked D-peptide looks identical to P1 10 (Figure 1) (data not shown) . Furthermore, the binding affinities of dwGsqhydp (K D ϭ 4ϫ10 -6 M) and vpGsqhyds (K D ϭ 6ϫ10 -6 M) are almost (Shoham, 1993) of the starting peptide VPGSQHIDS (light green, side chains excluded) and molecular model of the D-analog dwGsqhydp (red, side chains included) in complex with the antibody TE33 (grey). For visualization of the complexes the program ICM was applied (light chain, lower right side). (B) Crystal structure of the starting peptide GATPQDLNTML (light green, side chains excluded) and molecular model of the derived D-analog dwwGkssl (red, side chains included) in complex with the antibody CB4-1 (grey) (light chain, left side).
identical. The D-peptide vpGsqhyds was chosen because compared with the epitope it is an almost identical enantiomer. The TE33 binding L-peptide VPGSQHIDS (P1) and the docked D-peptide vpGsqhyds contain seven identical enantiomers and one identical glycine (Figure 1 ). Isoleucine 7 is substituted by D-tyrosine (bold) which is a key residue for binding. For that reason, the D-peptide was docked via template forcing assuming an identical side chain interaction for the starting and final peptide. To generate the same side chain interactions for the identical side chain as observed in the crystal structure, the backbone conformation of vpGsqhyds had to be altered, which seemed reasonable because no interaction between the backbone of the L-peptide and TE33 was observed (Shoham, 1993 ). In our model the D-peptide forms a loop with the C-terminus extending to the solvent ( Figure 3A) . The peptide contacts all hypervariable loops. The essential D-serine 4 makes an intramolecular hydrogen bond to glycine 3, D-glutamine 5 fits into a polar groove located in the heavy chain formed by Thr H31, Gly H33, Asn H52, Thr H53 and Tyr H54 making three hydrogen bonds ( Figure 3A , upper left side). D-Histidine 6 stacks with tyrosine 32 of the heavy chain. D-tyrosine 7 interacts with tryptophan 101 of the heavy chain, and makes an additional intramolecular hydrogen bond to the side chain of the essential D-serine 4. For details of hydrogen bonding, see Table IIIa. For the D-peptide saGdwwGkss (P2 11 ) in complex with CB4-1 no sequence similarity with the starting peptide GATPQDLNTML (P2) was observed. Therefore, an alternative docking procedure was applied. In this case a truncated peptide dwwGkssl peptide [the three N-terminal residues can be deleted without loss of binding (data not shown)] was docked to CB4-1 using the program ICM . ICM allows de novo docking of flexible ligands to protein surfaces. After 1.5 million Monte-Carlo steps the lowest energy conformation of the D-peptide dwwGkssl forms a loop which fits into the groove on the surface between the V L and V H domains contacting all hypervariable loops. The essential D-tryptophan residues 5 and 6 fit into pockets, as can be seen in Figure 3B . The side chain of D-tryptophan 6 makes an additional hydrogen bond to D-aspartate 92 of the light chain.
D-Lysine 8 forms salt bridges to aspartate residues 92 and 93 of the light chain, and D-serine 9 makes hydrogen bonds to the same aspartate residues. All hydrogen bonds of this complex are listed in Table IIIb (Frank, 1992; Kramer et al., 1994; Kramer and Schneider-Mergener, 1998) . More than 4000 D-analogs were tested for binding to the antibodies TE33 (Shoham, 1993) and CB4-1 . Substitutional analyses of peptide epitopes reveal key residues for interaction, residues that cannot be exchanged without loss of binding. In the case of the cholera toxin epitope VPGSQHIDS positions 1-6 and 8 cannot be exchanged at all by L-amino acids as shown in Figure 1 (upper left for comparison) . This is also reflected in the synthesis of the first D-analog library in which the first six positions cannot be substituted by any D-amino acid. The selection strategy chosen for the demonstrated transformation process is only one possibility of a multitude of other transformation routes. In principle, we have chosen strong binding D-analogs for the next synthesis rounds. However, in few cases (for instance P1 2 , Figure 1 ) a weak binding spot was chosen. In this particular case the selection rationale was to introduce a 'binding' D-substitution in the highly sensitive N-terminal region and overcoming this extremely low binding affinity (not measurable in ELISA, Table I ) in further transformation steps. This aim was achieved, although three more steps were needed. In the case of P1 8 a second substitution was performed at position 4, D-isoleucine by D-serine, because a significantly higher affinity was observed for the D-serine analog (see also Table I ). An important criterion for selecting starting peptides is to being able to Ser 4, His 6 ser 4, gln 5, his 6, tyr 7 Lys H99 Asp 6, Leu 7 asp 4, trp 5, trp 6 Trp H100a
Val 1, His 6, Ile 7, Asp 8 tyr 7, ser 9 Asp H100 Asp 6 asp 4 a Crystal structures (Shoham, 1993; Keitel et al., 1997) . b Models of complexes c The first three residues saG of P2 11 can be deleted without loss of binding. Therefore, the shortened D-peptide was docked. d The key residue D-leucine 11 also makes an intramolecular hydrophobic contact to D-tryptophan 5.
exchange key residues which is the most critical step. If several substitutions are possible we chose residues rendering solubility to the peptides. For later potential vaccination applications, residues more frequently found in epitopes like proline should be selected. Interestingly, a striking sequence similarity is observed between the starting and the final peptide. In contrast to other examples observed, the perfect D-enantiomer vpGsqhids does not bind to the same antibody. Neither do the retro analog SDIHQSGPV nor the retro-inverso analog sdihqsGpv (data not shown) (Benkirane et al., 1993 (Benkirane et al., , 1995 Guichard et al., 1994) . It is very unlikely that reversal of the terminal charges of the retro-inverso analog would lead to binding since the binding experiments were carried out on the membrane where the C-terminus is blocked for all peptides. Moreover, in the crystal structure and in the computer model both termini do not interact with the antibody.
In the second example, the transformation of the p24 (HIV-1) epitope GATPQDLNTML, a D-variant saGdwwGkssl was obtained which in this case had no similarity to the starting peptide. This D-variant binds to CB4-1 with lower affinity compared with the starting peptide. However, peptides P2 1 to P2 5 bind with comparable affinity. The drop in affinity from peptide P2 6 could not be restored. Selected peptides were checked for susceptibility towards proteolysis. The introduction of a few D-residues already completely stabilized the peptides. As an example, p24 epitope derived P2 5 retained high affinity combined with complete protease stability. For that reason it might not, in any case, be necessary to completely transform the original L-peptides.
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To provide further insight into the binding modes of the two D-peptides in complex with their respective antibodies, we generated two interaction models by computer assisted modelling. For the D-peptide P1 11 a surprising similarity with the starting peptide was observed. Glycine at position 3 was identical whereas positions 4-6 contained identical side chains. For the docking experiment we chose the vpGsqhyds enantiomer bearing almost identical side chains compared with the epitope. This molecule was deduced from the substitutional analysis of P1 11 (Figure 1 ). Since no backbone interactions were observed for these residues in the starting peptide (Shoham, 1993) we postulated an identical interaction for the identical side chains of the residues sqh in the D-peptide that were key residues for binding (Figure 1 ). D-Serine 4, which is critical for binding, can only be substituted by D-threonine, though with lower binding affinity. This is reflected in the structural model, as the side chain of D-serine forms a hydrogen bond, which is geometrically also possible for threonine, but its methyl group would distort the binding backbone geometry of the peptide. D-Glutamine 5 cannot be substituted at all due to hydrogen bonding to three antibody residues. In contrast to the wild-type peptide, D-histidine residue in the D-peptide, D-tyrosine 7, makes two hydrogen bonds, one intramolecular bond to D-serine 4, and the other to a water molecule which makes further contacts to both the light and heavy chain of TE33, explaining the importance of this residue. Comparing the backbone conformations of the starting and final peptide, the central part is very similar whereas the termini differ due to different side chain contacts ( Figure 3A) . It is not unusual that the binding affinity of the L-epitope is lower by one order of magnitude, although it has more key residues for interaction-V, P, G, S, Q, H and D compared with s, q, h, y (D-peptide)-because of similar observations in other peptide-antibody complexes (A.L. Kramer and Dong, personal communication) . However, the 947 gap volumes calculated for both complexes qualitatively correlate with the binding affinities which were also observed for the CB4-1 antibody complexes (Table IV) . For the p24 epitope-derived D-variant no sequence similarity to the starting peptide was observed. Therefore, we applied a de novo docking approach to propose an interaction model for the peptide dwwGkssl using the program ICM . In this case, the conformation of the starting and final peptide differ completely. In contrast to the L-peptide, the D-analog adopts a loop structure stabilized by three intramolecular hydrogen bonds (Table IIIb) . In the D-peptide, except for glycine and the two deleted N-terminal residues, all other side chains are critical for Column 1-5: surfaces in Å 2 ; column 6: volume in Å 3 . a X-ray structures (Shoham, 1993; Keitel et al., 1997) . b Models. c Only the Fv fragment of the antibody was taken into account. For all calculations, molecules were stripped off all hydrogens and water molecules, if present. Buried surfaces were calculated with ICM by computing the Connolly surfaces of the antibody alone and in complex with peptide. The waterprobe radius used was 1.7 Å. The vander-Waals parameters used by ICM are those of Momany et al. (1975) and Nemethy et al. (1983) . The gap volumes between the Fab and the peptides were computed using Surfnet (Laskowski, 1995) by inserting trial spheres between the receptor and the peptide. Minimum and maximum radius for the trial spheres were 1.0 and 4.0 Å, respectively.
binding. D-Aspartate 4 forms one intramolecular and one intermolecular hydrogen bond, D-tryptophan 5 forms two hydrogen bonds and fits into a binding groove formed mainly by the heavy chain, whereas D-tryptophan 6 fits into a hydrophobic groove now mainly formed by the light chain. The essential D-lysine forms hydrogen bonds to aspartate residues 92 and 93 of the light chain which can be restored by the exchange of D-arginine. D-Serine 9 forms a network of hydrogen bonds and D-leucine 11 makes an intramolecular hydrophobic contact to D-tryptophan 5, thus also stabilizing the loop structure. These findings are in good accordance with the substitutional analyses. We are currently working on the transformation of peptide ligands into D-analogs which are recognized by receptors others than antibodies. It seems possible to completely transform any starting L-molecule into a D-analog. Thus, this approach might be generally applicable to obtain biologically active D-peptides which is relevant with respect to the development of peptide hormones and antibiotics, neuropeptides and peptide-based vaccines (Guichard et al., 1994) . In any case, the aim is to create peptides that are stable towards proteolysis and that display the same if not enhanced biological activity than the original L-molecule. Depending on the affinity and/or activity the D-analog or one of the intermediates can then be used for the synthesis of peptidomimetics, thus optimizing biological activity, half-life time for parental or even oral administration (Fauchère and Thurieau, 1992) .
